Guidance

Clostridioides difficile infection: guidance on management and treatment

Options, agents, recommendations and algorithms for the treatment of Clostridioides difficile (C. difficile) infection.

• From: Public Health England
• Published: 1 June 2013
• Last updated: 23 July 2021 — See all updates

This publication was withdrawn on 13 July 2022

This guidance is out of date and has been superseded by the National Institute for Health and Care Excellence (NICE) guidance for Clostridioides infection: antimicrobial prescribing, known as NG199.

Documents

[Withdrawn] Updated guidance on the management and treatment of C. difficile infection

PDF, 1.61 MB, 29 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

The antimicrobial treatment recommendations in the existing Public Health England (PHE) Clostridioides difficile: guidance on management and treatment (2013) have been superseded by the National Institute for Health and Care Excellence (NICE) guideline on Clostridioides difficile infection (CDI).

A full update to the current PHE CDI guidelines is planned for later this year. Please continue to refer to the current PHE guidance for:

• management of life-threatening disease
• guidance on diagnosis
• guidance on infection control

Published 1 June 2013

Last updated 23 July 2021 + show all updates

1. 23 July 2021

   Added link to new NICE guidelines.

2. 6 September 2019

   Replaced name 'Clostridium difficile' with 'Clostridioides difficile' to reflect changes in microbial taxonomy.

3. 1 June 2013

   First published.